Fenproporex

CHEMBL2105566 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

188.3 g/mol

LogP

1.9

Phase

4

A stimulant medication that acts on the central nervous system to suppress appetite, used as a short-term aid for weight loss. It is metabolically converted to amphetamine in the body, which contributes to its anorectic effects. Due to its potential for dependence and cardiovascular risks, its use is tightly restricted or banned in many countries.

Moleküler Ağırlık

188,2700 g/mol

LogP

1,90

TPSA

35,80 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(Cc1ccccc1)NCCC#N

InChI

InChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3

Molecular Formula

C12H16N2

HBD / HBA

1 / 2

Döndürülebilir Bağlar

5

Ağır Atomlar

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A stimulant medication that acts on the central nervous system to suppress appetite, used as a short-term aid for weight loss. It is metabolically converted to amphetamine in the body, which contributes to its anorectic effects. Due to its potential for dependence and cardiovascular risks, its use is tightly restricted or banned in many countries.

Yes, Fenproporex is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105566. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 61810. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Fenproporex PillFYI'da

Yapı

Hızlı Veriler

Formül: C12H16N2

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.